0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Paediatric Oncology Therapeutics Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-32C13432
Home | Market Reports | Health| Health Conditions| Cancer
Global Paediatric Oncology Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Paediatric Oncology Therapeutics Market Research Report 2024

Code: QYRE-Auto-32C13432
Report
June 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Paediatric Oncology Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Paediatric Oncology Therapeutics Market

Paediatric Oncology Therapeutics Market

Children are affected by different forms of cancer than adults, there also exists a major difference between children and adults regarding treatment and development of new oncology therapies. The prominent variation is the concept of survival. With adult cancer patients, it is acceptable to look to immediate, 5 and 10-year survival rates, along with quality of life, for the best approximations of therapeutic success. On the other hand, a child cancer patient receives treatment to be cured. A typical difference between adult and pediatric oncologists is in treatment protocols; pediatric protocols are much more vigorous, often hitting patients “as hard as possible” to achieve a successful, long-term cure.
The global Paediatric Oncology Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Paediatric Oncology Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paediatric Oncology Therapeutics.

Report Scope

The Paediatric Oncology Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Paediatric Oncology Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paediatric Oncology Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Paediatric Oncology Therapeutics Market Report

Report Metric Details
Report Name Paediatric Oncology Therapeutics Market
CAGR 5%
Segment by Type
  • By Treatment
  • Chemotherapy
  • Radiotheraphy
  • Tumor Surgery
  • Blood and Marrow Transplantation
  • Drug Therapy
  • By Indication
  • Leukemia
  • Central Nervous System (CNS) disorders
  • Bone Tumors
  • Inflammatory disorders
  • Respiratory disorders
  • Retinoblastoma
Segment by Application
  • 0-15 Years Old
  • 15-19 Years Old
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company St Jude Children’s Research Hospital, St Louis Children’s Hospital, Monroe Carell Jr. Children’s Hospital at Vanderbilt, Birmingham Children’s Hospital, Royal Children’s Hospital, National Center for Child Health and Development, Dana-Dwek Children’s Hospital
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Paediatric Oncology Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Paediatric Oncology Therapeutics Market report?

Ans: The main players in the Paediatric Oncology Therapeutics Market are St Jude Children’s Research Hospital, St Louis Children’s Hospital, Monroe Carell Jr. Children’s Hospital at Vanderbilt, Birmingham Children’s Hospital, Royal Children’s Hospital, National Center for Child Health and Development, Dana-Dwek Children’s Hospital

What are the Application segmentation covered in the Paediatric Oncology Therapeutics Market report?

Ans: The Applications covered in the Paediatric Oncology Therapeutics Market report are 0-15 Years Old, 15-19 Years Old

What are the Type segmentation covered in the Paediatric Oncology Therapeutics Market report?

Ans: The Types covered in the Paediatric Oncology Therapeutics Market report are By Treatment, Chemotherapy, Radiotheraphy, Tumor Surgery, Blood and Marrow Transplantation, Drug Therapy, By Indication, Leukemia, Central Nervous System (CNS) disorders, Bone Tumors, Inflammatory disorders, Respiratory disorders, Retinoblastoma

1 Report Overview
1.1 Study Scope
1.2 Market Analysis By Treatment
1.2.1 Global Paediatric Oncology Therapeutics Market Size Growth Rate By Treatment: 2019 VS 2023 VS 2030
1.2.2 Chemotherapy
1.2.3 Radiotheraphy
1.2.4 Tumor Surgery
1.2.5 Blood and Marrow Transplantation
1.2.6 Drug Therapy
1.3 Market by Application
1.3.1 Global Paediatric Oncology Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 0-15 Years Old
1.3.3 15-19 Years Old
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Paediatric Oncology Therapeutics Market Perspective (2019-2030)
2.2 Paediatric Oncology Therapeutics Growth Trends by Region
2.2.1 Global Paediatric Oncology Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Paediatric Oncology Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Paediatric Oncology Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Paediatric Oncology Therapeutics Market Dynamics
2.3.1 Paediatric Oncology Therapeutics Industry Trends
2.3.2 Paediatric Oncology Therapeutics Market Drivers
2.3.3 Paediatric Oncology Therapeutics Market Challenges
2.3.4 Paediatric Oncology Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Paediatric Oncology Therapeutics Players by Revenue
3.1.1 Global Top Paediatric Oncology Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Paediatric Oncology Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Paediatric Oncology Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Paediatric Oncology Therapeutics Revenue
3.4 Global Paediatric Oncology Therapeutics Market Concentration Ratio
3.4.1 Global Paediatric Oncology Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paediatric Oncology Therapeutics Revenue in 2023
3.5 Paediatric Oncology Therapeutics Key Players Head office and Area Served
3.6 Key Players Paediatric Oncology Therapeutics Product Solution and Service
3.7 Date of Enter into Paediatric Oncology Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Paediatric Oncology Therapeutics Breakdown Data by Type
4.1 Global Paediatric Oncology Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Paediatric Oncology Therapeutics Forecasted Market Size by Type (2025-2030)
5 Paediatric Oncology Therapeutics Breakdown Data by Application
5.1 Global Paediatric Oncology Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Paediatric Oncology Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Paediatric Oncology Therapeutics Market Size (2019-2030)
6.2 North America Paediatric Oncology Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Paediatric Oncology Therapeutics Market Size by Country (2019-2024)
6.4 North America Paediatric Oncology Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Paediatric Oncology Therapeutics Market Size (2019-2030)
7.2 Europe Paediatric Oncology Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Paediatric Oncology Therapeutics Market Size by Country (2019-2024)
7.4 Europe Paediatric Oncology Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Paediatric Oncology Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Paediatric Oncology Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Paediatric Oncology Therapeutics Market Size (2019-2030)
9.2 Latin America Paediatric Oncology Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Paediatric Oncology Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Paediatric Oncology Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Paediatric Oncology Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Paediatric Oncology Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 St Jude Children’s Research Hospital
11.1.1 St Jude Children’s Research Hospital Company Detail
11.1.2 St Jude Children’s Research Hospital Business Overview
11.1.3 St Jude Children’s Research Hospital Paediatric Oncology Therapeutics Introduction
11.1.4 St Jude Children’s Research Hospital Revenue in Paediatric Oncology Therapeutics Business (2019-2024)
11.1.5 St Jude Children’s Research Hospital Recent Development
11.2 St Louis Children’s Hospital
11.2.1 St Louis Children’s Hospital Company Detail
11.2.2 St Louis Children’s Hospital Business Overview
11.2.3 St Louis Children’s Hospital Paediatric Oncology Therapeutics Introduction
11.2.4 St Louis Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2019-2024)
11.2.5 St Louis Children’s Hospital Recent Development
11.3 Monroe Carell Jr. Children’s Hospital at Vanderbilt
11.3.1 Monroe Carell Jr. Children’s Hospital at Vanderbilt Company Detail
11.3.2 Monroe Carell Jr. Children’s Hospital at Vanderbilt Business Overview
11.3.3 Monroe Carell Jr. Children’s Hospital at Vanderbilt Paediatric Oncology Therapeutics Introduction
11.3.4 Monroe Carell Jr. Children’s Hospital at Vanderbilt Revenue in Paediatric Oncology Therapeutics Business (2019-2024)
11.3.5 Monroe Carell Jr. Children’s Hospital at Vanderbilt Recent Development
11.4 Birmingham Children’s Hospital
11.4.1 Birmingham Children’s Hospital Company Detail
11.4.2 Birmingham Children’s Hospital Business Overview
11.4.3 Birmingham Children’s Hospital Paediatric Oncology Therapeutics Introduction
11.4.4 Birmingham Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2019-2024)
11.4.5 Birmingham Children’s Hospital Recent Development
11.5 Royal Children’s Hospital
11.5.1 Royal Children’s Hospital Company Detail
11.5.2 Royal Children’s Hospital Business Overview
11.5.3 Royal Children’s Hospital Paediatric Oncology Therapeutics Introduction
11.5.4 Royal Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2019-2024)
11.5.5 Royal Children’s Hospital Recent Development
11.6 National Center for Child Health and Development
11.6.1 National Center for Child Health and Development Company Detail
11.6.2 National Center for Child Health and Development Business Overview
11.6.3 National Center for Child Health and Development Paediatric Oncology Therapeutics Introduction
11.6.4 National Center for Child Health and Development Revenue in Paediatric Oncology Therapeutics Business (2019-2024)
11.6.5 National Center for Child Health and Development Recent Development
11.7 Dana-Dwek Children’s Hospital
11.7.1 Dana-Dwek Children’s Hospital Company Detail
11.7.2 Dana-Dwek Children’s Hospital Business Overview
11.7.3 Dana-Dwek Children’s Hospital Paediatric Oncology Therapeutics Introduction
11.7.4 Dana-Dwek Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2019-2024)
11.7.5 Dana-Dwek Children’s Hospital Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Paediatric Oncology Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Chemotherapy
    Table 3. Key Players of Radiotheraphy
    Table 4. Key Players of Tumor Surgery
    Table 5. Key Players of Blood and Marrow Transplantation
    Table 6. Key Players of Drug Therapy
    Table 7. Global Paediatric Oncology Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Paediatric Oncology Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Paediatric Oncology Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Paediatric Oncology Therapeutics Market Share by Region (2019-2024)
    Table 11. Global Paediatric Oncology Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Paediatric Oncology Therapeutics Market Share by Region (2025-2030)
    Table 13. Paediatric Oncology Therapeutics Market Trends
    Table 14. Paediatric Oncology Therapeutics Market Drivers
    Table 15. Paediatric Oncology Therapeutics Market Challenges
    Table 16. Paediatric Oncology Therapeutics Market Restraints
    Table 17. Global Paediatric Oncology Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Paediatric Oncology Therapeutics Market Share by Players (2019-2024)
    Table 19. Global Top Paediatric Oncology Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paediatric Oncology Therapeutics as of 2023)
    Table 20. Ranking of Global Top Paediatric Oncology Therapeutics Companies by Revenue (US$ Million) in 2023
    Table 21. Global 5 Largest Players Market Share by Paediatric Oncology Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Paediatric Oncology Therapeutics Product Solution and Service
    Table 24. Date of Enter into Paediatric Oncology Therapeutics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Paediatric Oncology Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Paediatric Oncology Therapeutics Revenue Market Share by Type (2019-2024)
    Table 28. Global Paediatric Oncology Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Paediatric Oncology Therapeutics Revenue Market Share by Type (2025-2030)
    Table 30. Global Paediatric Oncology Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Paediatric Oncology Therapeutics Revenue Market Share by Application (2019-2024)
    Table 32. Global Paediatric Oncology Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Paediatric Oncology Therapeutics Revenue Market Share by Application (2025-2030)
    Table 34. North America Paediatric Oncology Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. North America Paediatric Oncology Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 36. North America Paediatric Oncology Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Europe Paediatric Oncology Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Europe Paediatric Oncology Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 39. Europe Paediatric Oncology Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Asia-Pacific Paediatric Oncology Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Asia-Pacific Paediatric Oncology Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 42. Asia-Pacific Paediatric Oncology Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 43. Latin America Paediatric Oncology Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Latin America Paediatric Oncology Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Latin America Paediatric Oncology Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Middle East & Africa Paediatric Oncology Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Middle East & Africa Paediatric Oncology Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Middle East & Africa Paediatric Oncology Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 49. St Jude Children’s Research Hospital Company Detail
    Table 50. St Jude Children’s Research Hospital Business Overview
    Table 51. St Jude Children’s Research Hospital Paediatric Oncology Therapeutics Product
    Table 52. St Jude Children’s Research Hospital Revenue in Paediatric Oncology Therapeutics Business (2019-2024) & (US$ Million)
    Table 53. St Jude Children’s Research Hospital Recent Development
    Table 54. St Louis Children’s Hospital Company Detail
    Table 55. St Louis Children’s Hospital Business Overview
    Table 56. St Louis Children’s Hospital Paediatric Oncology Therapeutics Product
    Table 57. St Louis Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2019-2024) & (US$ Million)
    Table 58. St Louis Children’s Hospital Recent Development
    Table 59. Monroe Carell Jr. Children’s Hospital at Vanderbilt Company Detail
    Table 60. Monroe Carell Jr. Children’s Hospital at Vanderbilt Business Overview
    Table 61. Monroe Carell Jr. Children’s Hospital at Vanderbilt Paediatric Oncology Therapeutics Product
    Table 62. Monroe Carell Jr. Children’s Hospital at Vanderbilt Revenue in Paediatric Oncology Therapeutics Business (2019-2024) & (US$ Million)
    Table 63. Monroe Carell Jr. Children’s Hospital at Vanderbilt Recent Development
    Table 64. Birmingham Children’s Hospital Company Detail
    Table 65. Birmingham Children’s Hospital Business Overview
    Table 66. Birmingham Children’s Hospital Paediatric Oncology Therapeutics Product
    Table 67. Birmingham Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2019-2024) & (US$ Million)
    Table 68. Birmingham Children’s Hospital Recent Development
    Table 69. Royal Children’s Hospital Company Detail
    Table 70. Royal Children’s Hospital Business Overview
    Table 71. Royal Children’s Hospital Paediatric Oncology Therapeutics Product
    Table 72. Royal Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2019-2024) & (US$ Million)
    Table 73. Royal Children’s Hospital Recent Development
    Table 74. National Center for Child Health and Development Company Detail
    Table 75. National Center for Child Health and Development Business Overview
    Table 76. National Center for Child Health and Development Paediatric Oncology Therapeutics Product
    Table 77. National Center for Child Health and Development Revenue in Paediatric Oncology Therapeutics Business (2019-2024) & (US$ Million)
    Table 78. National Center for Child Health and Development Recent Development
    Table 79. Dana-Dwek Children’s Hospital Company Detail
    Table 80. Dana-Dwek Children’s Hospital Business Overview
    Table 81. Dana-Dwek Children’s Hospital Paediatric Oncology Therapeutics Product
    Table 82. Dana-Dwek Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2019-2024) & (US$ Million)
    Table 83. Dana-Dwek Children’s Hospital Recent Development
    Table 84. Research Programs/Design for This Report
    Table 85. Key Data Information from Secondary Sources
    Table 86. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Paediatric Oncology Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Paediatric Oncology Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Chemotherapy Features
    Figure 4. Radiotheraphy Features
    Figure 5. Tumor Surgery Features
    Figure 6. Blood and Marrow Transplantation Features
    Figure 7. Drug Therapy Features
    Figure 8. Global Paediatric Oncology Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Paediatric Oncology Therapeutics Market Share by Application: 2023 VS 2030
    Figure 10. 0-15 Years Old Case Studies
    Figure 11. 15-19 Years Old Case Studies
    Figure 12. Paediatric Oncology Therapeutics Report Years Considered
    Figure 13. Global Paediatric Oncology Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Paediatric Oncology Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Paediatric Oncology Therapeutics Market Share by Region: 2023 VS 2030
    Figure 16. Global Paediatric Oncology Therapeutics Market Share by Players in 2023
    Figure 17. Global Top Paediatric Oncology Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paediatric Oncology Therapeutics as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Paediatric Oncology Therapeutics Revenue in 2023
    Figure 19. North America Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Paediatric Oncology Therapeutics Market Share by Country (2019-2030)
    Figure 21. United States Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Paediatric Oncology Therapeutics Market Share by Country (2019-2030)
    Figure 25. Germany Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. France Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. U.K. Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Italy Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Russia Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Nordic Countries Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Paediatric Oncology Therapeutics Market Share by Region (2019-2030)
    Figure 33. China Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Japan Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. South Korea Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Southeast Asia Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. India Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Australia Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Paediatric Oncology Therapeutics Market Share by Country (2019-2030)
    Figure 41. Mexico Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Brazil Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Paediatric Oncology Therapeutics Market Share by Country (2019-2030)
    Figure 45. Turkey Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Saudi Arabia Paediatric Oncology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. St Jude Children’s Research Hospital Revenue Growth Rate in Paediatric Oncology Therapeutics Business (2019-2024)
    Figure 48. St Louis Children’s Hospital Revenue Growth Rate in Paediatric Oncology Therapeutics Business (2019-2024)
    Figure 49. Monroe Carell Jr. Children’s Hospital at Vanderbilt Revenue Growth Rate in Paediatric Oncology Therapeutics Business (2019-2024)
    Figure 50. Birmingham Children’s Hospital Revenue Growth Rate in Paediatric Oncology Therapeutics Business (2019-2024)
    Figure 51. Royal Children’s Hospital Revenue Growth Rate in Paediatric Oncology Therapeutics Business (2019-2024)
    Figure 52. National Center for Child Health and Development Revenue Growth Rate in Paediatric Oncology Therapeutics Business (2019-2024)
    Figure 53. Dana-Dwek Children’s Hospital Revenue Growth Rate in Paediatric Oncology Therapeutics Business (2019-2024)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Personalizing Cancer Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-26D6003
Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Global Chemotherapy Chairs Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-26D13514
Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Drugs for Non-Small Cell Lung Cancer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-33S12067
Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Anti-Oral Mucositis Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-5V5924
Mon Oct 07 00:00:00 UTC 2024

Add to Cart